Search bioRxiv⌕ Search

Biology subjects

Fraser, T. A.

Publications and source records attributed to Fraser, T. A..

3 recordsLinked to original sources

The HSV-1 LAT enhancer regulates locus-specific H3.1 enrichment during early lytic infection

The Herpes Simplex Virus 1 (HSV-1) genome undergoes extensive chromatinization following entry into the nucleus, yet how viral regulatory elements influence this process during lytic infection remains poorly understood. The HSV-1 latency-associated transcript enhancer (LTE) is well established as a key element in the regulation of latency and reactivation, but its role during the productive infection has not been defined. Here, we identify a role for the LTE in regulating chromatin composition on the lytic HSV-1 genome. Deletion of a 310-bp region within the LTE selectively reduced enrichment of the canonical histone H3.1 at specific viral lytic genes, including ICP4 and ICP8, without altering H3.3 enrichment. This phenotype was not reproduced using a second LTE deletion that disrupted enhancer activity, indicating that regulation of H3.1 enrichment is separable from the function of the enhancer. LTE-dependent H3.1 enrichment persisted in the absence of viral DNA replication and was accompanied by reduced occupancy of the H3.1 histone chaperone CAF-1. However, depletion of CAF-1 did not substantially reduce H3.1 enrichment, indicating that additional mechanisms contribute to H3.1 association with the viral genome. Together, these findings reveal that the HSV-1 LTE regulates locus-specific chromatin composition during early lytic infection and identify a previously unrecognized connection between a viral enhancer and histone H3.1 enrichment on the incoming viral genome.

microbiology↗

Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp.

Several members of the Gram-negative environmental bacterial genus, Achromobacter, are associated with serious infections in immunocompromised individuals, of which Achromobacter xylosoxidans is the most common. Despite their pathogenic potential, comparatively little is understood about these intrinsically drug-resistant bacteria and their role in disease, leading to suboptimal diagnosis and management of Achromobacter infections. Here, we performed comparative genomics of 158 Achromobacter spp. genomes to robustly identify species boundaries, to reassign several incorrectly speciated taxa, and to identify genetic sequences specific for the Achromobacter genus and for A. xylosoxidans. Next, we developed a Black Hole Quencher probe-based duplex real-time PCR assay, Ac-Ax, for the rapid and simultaneous detection of Achromobacter spp. and A. xylosoxidans from both purified colonies and polymicrobial clinical specimens. Ac-Ax was tested on 119 isolates identified as Achromobacter spp. using phenotypic or genotypic methods. In comparison to these routine diagnostic methods, the duplex assay showed superior identification of Achromobacter spp. and A. xylosoxidans, with five Achromobacter isolates failing to amplify with Ac-Ax confirmed to be different genera according to 16S rRNA gene sequencing. Ac-Ax quantified both Achromobacter spp. and A. xylosoxidans down to [~]110 genome equivalents, and detected down to [~]12 and [~]1 genome equivalent/s, respectively. In silico analysis, and laboratory testing of 34 non-Achromobacter isolates and 38 adult CF sputa, confirmed duplex assay specificity and sensitivity. We demonstrate that the Ac-Ax duplex assay provides a robust, sensitive, and cost-effective method for the simultaneous detection of all Achromobacter spp. and A. xylosoxidans, and will facilitate the rapid and accurate diagnosis of this important group of pathogens.

microbiology↗

Quantitative real-time PCR assay for the rapid identification of the multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia

Stenotrophomonas maltophilia is emerging as an important cause of disease in nosocomial and community-acquired settings, including bloodstream, wound and catheter-associated infections. Cystic fibrosis airways also provide optimal growth conditions for various opportunistic pathogens with high antibiotic tolerance, including S. maltophilia. Currently, there is no rapid, cost-effective, and accurate molecular method for detecting this potentially life-threatening pathogen, particularly in polymicrobial specimens, suggesting that its true prevalence may be underestimated. Here, we used large-scale comparative genomics to identify a specific genetic target for S. maltophilia, with subsequent development and validation of a real-time PCR assay for its detection. Analysis of 165 Stenotrophomonas spp. genomes identified a 4kb region specific to S. maltophilia, which was targeted for Black Hole Quencher assay design. Our assay yielded the positive detection of 89 of 89 (100%) clinical S. maltophilia strains, and no amplification of 23 non-S. maltophilia clinical isolates. S. maltophilia was detected in 10/16 CF sputa, demonstrating the utility for direct detection in respiratory specimens. The assay demonstrated good sensitivity, with limits of detection and quantitation on pure culture of ~10 and ~100 genome equivalents, respectively. Our assay provides a highly specific, sensitive, and cost-effective method for the accurate identification of S. maltophilia, and will improve the diagnosis and treatment of this under-recognized pathogen by enabling its accurate and rapid detection from polymicrobial clinical and environmental samples.

microbiology↗